Complete Filing Data
BIOFORCE NANOSCIENCES HOLDINGS, INC. reported Stockholders Equity of -$1.35 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BIOFORCE NANOSCIENCES HOLDINGS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | -$490.4K | -$472.0K | -$485.5K | -$502.0K | -$158.4M | -$46.5K | -$67.7K | -$31.3K |
| General And Administrative Expense | $67.4K | $49.0K | $62.5K | $79.0K | $81.0K | $50.9K | $71.4K | $32.5K |
| Operating Expenses | $490.4K | $472.0K | $485.5K | $502.0K | $158.4M | $50.9K | ||
| Compensation Expense Excluding Cost Of Good And Service Sold | $423.0K | $423.0K | $423.0K | $423.0K | $158.3M | |||
| Operating Income Loss | -$46.5K | -$66.7K | -$31.3K | |||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$46.5K | -$67.7K | -$31.3K | |||||
| Revenues | $17.8K | $16.3K | $4.5K | |||||
| Gross Profit | $4.4K | $4.7K | $1.3K | |||||
| Cost Of Revenue | $13.4K | $11.6K | $3.2K | |||||
| Net Income Loss Available To Common Stockholders Basic | ||||||||
| Income Tax Expense Benefit | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$115.9K | -$122.8K | -$934.7K | -$122.0K | -$114.4K | -$130.8K | -$113.6K | -$113.9K | -$130.0K | -$122.6K | -$115.8K | -$132.4K | -$113.9K | -$122.3K | -$145.1K | -$117.9K | -$126.7K | -$158.0M | -$6.3K | -$7.2K | -$12.9K | -$6.6K | -$28.5K | -$24.0K | -$2.2K |
| General And Administrative Expense | $10.2K | $17.0K | $27.7K | $16.3K | $8.7K | $25.1K | $7.9K | $8.2K | $24.3K | $16.8K | $10.0K | $26.7K | $8.1K | $16.6K | $39.3K | $11.6K | $21.5K | $31.7K | $8.1K | $8.1K | $14.5K | $8.2K | $28.9K | $24.0K | $2.2K |
| Operating Expenses | $115.9K | $122.8K | $133.5K | $122.0K | $114.4K | $130.8K | $113.6K | $113.9K | $130.0K | $122.6K | $115.8K | $132.4K | $113.9K | $122.3K | $145.1K | $117.9K | $126.7K | $158.0M | $8.1K | $8.1K | $14.5K | ||||
| Compensation Expense Excluding Cost Of Good And Service Sold | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $106.3K | $105.2K | $158.0M | |||||||
| Operating Income Loss | -$115.9K | -$122.8K | -$133.5K | -$122.0K | -$114.4K | -$6.3K | -$7.2K | -$12.9K | -$6.6K | -$27.5K | -$24.0K | -$2.2K | |||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$126.7K | -$158.0M | -$6.3K | -$7.2K | -$12.9K | -$6.6K | -$28.5K | -$2.2K | |||||||||||||||||
| Revenues | $6.0K | $6.0K | $5.9K | $5.5K | $5.1K | ||||||||||||||||||||
| Gross Profit | $1.7K | $947.00 | $1.7K | $1.6K | $1.4K | ||||||||||||||||||||
| Cost Of Revenue | $4.2K | $5.0K | $4.2K | $3.9K | $3.6K | ||||||||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$115.9K | -$122.8K | -$934.7K | -$122.0K | -$114.4K | -$130.8K | |||||||||||||||||||
| Income Tax Expense Benefit |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.3M | -$861.9K | -$359.9K | $47.3K | $29.8K | $8.2K | $2.3K | ||
| Cash And Cash Equivalents At Carrying Value | $638.00 | $734.00 | $11.1K | $39.9K | $52.9K | $29.4K | $14.3K | $14.3K | |
| Retained Earnings Accumulated Deficit | -$160.6M | -$160.2M | -$159.7M | -$159.2M | -$761.8K | -$715.2K | -$647.5K | ||
| Liabilities Current | $1.8M | $1.3M | $873.0K | $399.8K | $11.6K | $5.3K | $12.7K | ||
| Liabilities And Stockholders Equity | $638.00 | $734.00 | $11.1K | $39.9K | $58.9K | $35.1K | $20.9K | ||
| Liabilities | $1.8M | $1.3M | $873.0K | $399.8K | $11.6K | $5.3K | $12.7K | ||
| Common Stock Value | $29.3K | $29.3K | $29.3K | $29.3K | $15.3K | $15.3K | $76.3K | ||
| Assets Current | $638.00 | $734.00 | $11.1K | $39.9K | $58.9K | $35.1K | $20.9K | ||
| Assets | $638.00 | $734.00 | $11.1K | $39.9K | $58.9K | $35.1K | $20.9K | ||
| Additional Paid In Capital Common Stock | $158.8M | $158.8M | $158.8M | $158.8M | $793.8K | $729.8K | $579.4K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $734.00 | $11.1K | $39.9K | ||||||
| Accounts Payable And Accrued Liabilities Current | $2.6K | $398.00 | $6.3K | $5.1K | $10.2K | $5.3K | $12.7K | ||
| Accrued Salaries Current And Noncurrent | $1.6M | $1.2M | $750.5K | $327.5K | |||||
| Common Stock Issued To Pay Accounts Payable | $1.3K | $16.2K | $11.8K | $11.3K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $224.00 | -$96.00 | -$10.4K | -$28.8K | -$13.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | |||||||||
| Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$13.0K | $23.5K | $15.1K | ||||||
| Accounts Receivable Net Current | $5.7K | $4.5K | |||||||
| Gain Loss On Liability Settlement | $998.00 | ||||||||
| Stock Payable Current | $1.3K | ||||||||
| Common Stock Issued To Pay Accounts Payable Value | |||||||||
| Common And Preferred Stock Issued For Current Year Board Of Directors Compensation | $158.0M | ||||||||
| Gains Losses On Extinguishment Of Debt | |||||||||
| Common Stock Issued To Satisfy Liabilities | |||||||||
| Common Stock Issued To Pay Stock Payable | $1.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$499.9K | -$384.0K | -$261.2K | -$2.3M | -$2.2M | -$2.1M | -$2.0M | -$1.8M | -$1.7M | -$1.6M | -$1.5M | -$1.2M | -$1.1M | -$994.3K | -$741.2K | -$627.3K | -$505.0K | -$237.3K | -$119.4K | $7.3K | $48.4K | $41.9K | $34.2K | $23.9K | $16.3K | $14.1K | |
| Cash And Cash Equivalents At Carrying Value | $784.00 | $905.00 | $13.8K | $862.00 | $1.6K | $667.00 | $640.00 | $686.00 | $654.00 | $686.00 | $750.00 | $9.2K | $11.1K | $27.3K | $27.3K | $31.8K | $39.9K | $39.9K | $46.9K | $46.9K | $41.0K | $35.1K | $23.9K | $23.9K | $18.8K | $14.3K | |
| Retained Earnings Accumulated Deficit | -$162.3M | -$162.2M | -$162.1M | -$161.1M | -$161.0M | -$160.9M | -$160.8M | -$160.5M | -$160.4M | -$160.3M | -$160.0M | -$159.9M | -$159.8M | -$159.6M | -$159.4M | -$159.3M | -$159.0M | -$158.9M | -$158.8M | -$741.6K | -$735.2K | -$728.1K | -$706.6K | ||||
| Liabilities Current | $500.7K | $384.9K | $275.0K | $2.3M | $2.2M | $2.1M | $2.0M | $1.7M | $1.6M | $1.5M | $1.2M | $1.1M | $1.0M | $768.5K | $654.7K | $536.9K | $277.2K | $162.2K | $44.1K | $4.5K | $5.0K | $6.8K | $5.5K | ||||
| Liabilities And Stockholders Equity | $784.00 | $905.00 | $13.8K | $862.00 | $1.6K | $667.00 | $640.00 | $686.00 | $654.00 | $686.00 | $750.00 | $9.2K | $11.1K | $27.4K | $27.4K | $32.0K | $39.9K | $42.8K | $51.4K | $52.9K | $46.9K | $41.0K | $29.4K | ||||
| Liabilities | $500.7K | $384.9K | $275.0K | $2.3M | $2.2M | $2.1M | $2.0M | $1.7M | $1.6M | $1.5M | $1.2M | $1.1M | $1.0M | $768.5K | $654.7K | $536.9K | $277.2K | $162.2K | $44.1K | $4.5K | $5.0K | $6.8K | $5.5K | ||||
| Common Stock Value | $33.5K | $33.5K | $33.5K | $29.3K | $29.3K | $29.3K | $29.3K | $29.3K | $29.3K | $29.3K | $29.3K | $29.3K | $29.3K | $29.3K | $29.3K | $29.3K | $15.3K | $15.3K | $15.3K | $76.3K | $76.3K | $76.3K | $76.3K | ||||
| Assets Current | $784.00 | $905.00 | $13.8K | $862.00 | $1.6K | $667.00 | $640.00 | $686.00 | $654.00 | $686.00 | $750.00 | $9.2K | $11.1K | $27.4K | $27.4K | $32.0K | $39.9K | $42.8K | $51.4K | $52.9K | $46.9K | $41.0K | $29.4K | ||||
| Assets | $784.00 | $905.00 | $13.8K | $862.00 | $1.6K | $667.00 | $640.00 | $686.00 | $654.00 | $686.00 | $750.00 | $9.2K | $11.1K | $27.4K | $27.4K | $32.0K | $39.9K | $42.8K | $51.4K | $52.9K | $46.9K | $41.0K | $29.4K | ||||
| Additional Paid In Capital Common Stock | $161.8M | $161.8M | $161.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $158.8M | $713.6K | $700.8K | $685.9K | $654.3K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $784.00 | $905.00 | $13.8K | $862.00 | $1.6K | $667.00 | $640.00 | $638.00 | $686.00 | $654.00 | $686.00 | $750.00 | $9.2K | $11.1K | $27.3K | $27.3K | $31.8K | ||||||||||
| Accounts Payable And Accrued Liabilities Current | $10.7K | $10.5K | $21.3K | $8.8K | $6.3K | $5.4K | $10.1K | $1.1K | $1.1K | $1.6K | $844.00 | $400.00 | $435.00 | $1.0K | $12.2K | $782.00 | $4.5K | $5.0K | $6.8K | $5.5K | |||||||
| Accrued Salaries Current And Noncurrent | $421.8K | $317.2K | $211.5K | $2.0M | $1.9M | $1.8M | $1.7M | $1.5M | $1.4M | $1.3M | $1.1M | $962.0K | $856.3K | $644.8K | $539.0K | $433.3K | $221.2K | $114.9K | $9.7K | ||||||||
| Common Stock Issued To Pay Accounts Payable | $1.3K | $5.0K | $4.2K | $4.1K | $3.6K | $4.2K | |||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $12.9K | $2.00 | -$48.00 | ||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$8.0K | -$6.0K | |||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$6.0K | $5.7K | $4.5K | ||||||||||||||||||||||||
| Accounts Receivable Net Current | $6.0K | $6.0K | $5.9K | $5.5K | |||||||||||||||||||||||
| Gain Loss On Liability Settlement | $998.00 | ||||||||||||||||||||||||||
| Stock Payable Current | |||||||||||||||||||||||||||
| Common Stock Issued To Pay Accounts Payable Value | $1.3K | ||||||||||||||||||||||||||
| Common And Preferred Stock Issued For Current Year Board Of Directors Compensation | $158.0M | ||||||||||||||||||||||||||
| Gains Losses On Extinguishment Of Debt | -$801.2K | ||||||||||||||||||||||||||
| Common Stock Issued To Satisfy Liabilities | $3.0M | ||||||||||||||||||||||||||
| Common Stock Issued To Pay Stock Payable |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$61.3K | -$46.7K | -$68.4K | -$77.8K | -$80.2K | -$24.4K | -$62.5K | -$25.9K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $6.2K | $2.3K | -$5.9K | $1.2K | -$5.2K | $4.9K | -$8.4K | $9.9K |
| Net Cash Provided By Used In Financing Activities | $61.5K | $46.6K | $58.0K | $49.0K | $67.2K | $47.9K | ||
| Proceeds From Related Party Debt | $53.4K | $46.6K | $57.9K | $49.0K | $67.2K | |||
| Increase Decrease In Accrued Salaries | $423.0K | $423.0K | $423.0K | $423.0K | $327.5K | |||
| Increase Decrease In Prepaid Expense | -$40.00 | $40.00 | -$6.0K | $6.0K | -$2.1K | |||
| Proceeds From Contributed Capital | $47.9K | $77.5K | $25.9K | |||||
| Increase Decrease In Accounts Receivable | -$5.7K | $1.2K | $4.5K | |||||
| Share Based Compensation |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$15.2K | -$17.6K | -$23.1K | -$32.9K | -$32.3K | -$39.6K | -$7.4K | -$25.4K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $12.5K | $7.5K | $1.2K | -$6.3K | $7.1K | -$9.5K | $5.5K | -$4.1K |
| Net Cash Provided By Used In Financing Activities | $28.2K | $17.6K | $23.0K | $32.9K | $24.3K | $33.6K | $13.2K | |
| Proceeds From Related Party Debt | $28.2K | $17.6K | $23.0K | $32.9K | $24.3K | $33.6K | ||
| Increase Decrease In Accrued Salaries | $105.8K | $105.8K | $105.8K | $105.8K | $105.8K | $9.7K | ||
| Increase Decrease In Prepaid Expense | -$30.00 | $120.00 | -$1.5K | $1.8K | ||||
| Proceeds From Contributed Capital | $13.2K | $29.9K | ||||||
| Increase Decrease In Accounts Receivable | $115.00 | -$4.5K | ||||||
| Share Based Compensation | $158.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.02 | -$0.02 | -$0.02 | -$0.02 | -$9.72 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 29.3M | 29.3M | 29.3M | 29.3M | 15.3M | 15.3M | 76.3M | |
| Common Stock Shares Issued | 29.3M | 29.3M | 29.3M | 29.3M | 15.3M | 15.3M | 76.3M | |
| Common Stock Shares Authorized | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 29.3M | 16.3M | 15.3M | 15.3M | 76.2M | |||
| Earnings Per Share Basic | $-0.02 | $-0.02 | $-0.02 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 29.3M | 29.3M | 29.3M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 29.3M | 29.3M | 29.3M | |||||
| Preferred Stock Shares Authorized | 90.0M | 100.0M | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Outstanding | ||||||||
| Weighted Average Number Of Common Shares Basic And Diluted | 29.3M | 29.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | -$0.03 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | $0.00 | -$10.35 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 33.5M | 33.5M | 33.5M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 15.3M | 15.3M | 15.3M | 76.3M | 76.3M | 76.3M | 76.3M | |||||
| Common Stock Shares Issued | 33.5M | 33.5M | 33.5M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 15.3M | 15.3M | 15.3M | 76.3M | 76.3M | 76.3M | 76.3M | |||||
| Common Stock Shares Authorized | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | 900.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 29.3M | 29.3M | 29.3M | 15.3M | 15.3M | 15.3M | 15.3M | 15.3M | 15.3M | 76.3M | 76.3M | 76.3M | 76.1M | |||||||||||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $-0.03 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $29,271,755.00 | $0.00 | $0.00 | $29,271,755.00 | |||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 33.5M | 32.2M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 0.00 | 29.3M | 29.3M | 0.00 | ||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 33.5M | 33.5M | 32.2M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | 29.3M | ||||||||||||||||
| Preferred Stock Shares Authorized | 90.0M | 90.0M | 90.0M | 90.0M | 100.0M | 100.0M | 100.0M | 100.0M | 50.0M | |||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||
| Weighted Average Number Of Common Shares Basic And Diluted | 29.3M | 29.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Due To Related Parties | $220.7K | $174.1K | $116.2K | |||||
| Prepaid Expense Current | $40.00 | $6.0K | $2.1K | |||||
| Due To Related Parties Current | $67.2K | |||||||
| Capital Contribution Directors | $47.9K | $77.5K | $25.9K | |||||
| Stock Issued During Period Value Conversion Of Units | $8.1K | $100.00 | ||||||
| Stock Issued During Period Value Issued For Services | $158.0M | |||||||
| Net Loss Per Common Shares Basic And Diluted | -0.02 | -0.02 | ||||||
| Capital Contributions | $100.00 | |||||||
| Increase Decrease Stock Payble | -$1.3K | |||||||
| Captial Contributions | $8.1K | |||||||
| Stock Issued During Period Value Employee Benefit Plan |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Due To Related Parties | $68.2K | $57.2K | $42.2K | $274.1K | $260.0K | $251.6K | $238.3K | $213.7K | $197.1K | $197.1K | ||||||||||||||||
| Prepaid Expense Current | $10.00 | $70.00 | $100.00 | $120.00 | $3.0K | $4.5K | ||||||||||||||||||||
| Due To Related Parties Current | $164.7K | $156.9K | $149.1K | $116.2K | $123.3K | $114.7K | $91.5K | $56.0K | $47.4K | $33.6K | ||||||||||||||||
| Capital Contribution Directors | $7.8K | $10.7K | $13.2K | $10.6K | $26.5K | $29.9K | ||||||||||||||||||||
| Stock Issued During Period Value Conversion Of Units | $8.0K | $75.00 | $100.00 | |||||||||||||||||||||||
| Stock Issued During Period Value Issued For Services | $158.0M | |||||||||||||||||||||||||
| Net Loss Per Common Shares Basic And Diluted | 0.00 | 0.00 | ||||||||||||||||||||||||
| Capital Contributions | ||||||||||||||||||||||||||
| Increase Decrease Stock Payble | ||||||||||||||||||||||||||
| Captial Contributions | ||||||||||||||||||||||||||
| Stock Issued During Period Value Employee Benefit Plan | $100.00 |
Most recent annual filing with the SEC: April 8, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.